DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "eClinical Solutions Market - Global Forecast to 2022" report to their offering.
The global eClinical solutions market is estimated to reach 7.61 billion by 2022, at a high CAGR of 12.4% in the forecast period (2017-2022).
The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. However, a dearth of skilled research professionals and concerns over patient data privacy are hampering the adoption of these solutions.
On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.
- Bio-Optronics, Inc.
- Bioclinica, Inc. (A Subsidiary of Cinven)
- CRF Health
- Datatrak International, Inc.
- Eclinical Solutions, LLC.
- ERT Clinical
- Maxisit Inc.
- Medidata Solutions, Inc.
- Merge Healthcare Incorporated
- Omnicomm Systems, Inc.
- Oracle Corporation
Parexel International Corporation
Key Topics Covered:
2 Research Methodology
4 Premium Insights
5 Market Overview
6 Global Eclinical Solutions Market, By Product
7 Eclinical Solutions Market, By Delivery Mode
8 Global Eclinical Solutions Market, By Clinical Trial Phase
9 Eclinical Solutions Market, By End User
10 Eclinical Solutions Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/w7zr6s/eclinical